{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:18:41Z","timestamp":1761164321813,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.niox.2020.01.004","type":"journal-article","created":{"date-parts":[[2020,1,12]],"date-time":"2020-01-12T01:06:33Z","timestamp":1578791193000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhaled nitric oxide to control platelet hyper-reactivity in patients with acute submassive pulmonary embolism"],"prefix":"10.1016","volume":"96","author":[{"given":"Jeffrey A.","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Puskarich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Zagorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2020.01.004_bib1","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1097\/CCM.0b013e318226678e","article-title":"Pulmonary vascular reserve during experimental pulmonary embolism: effects of a soluble guanylate cyclase stimulator, BAY 41-8543","volume":"39","author":"Watts","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.niox.2020.01.004_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00171913","article-title":"Severe pulmonary embolism decreases plasma L-arginine","volume":"43","author":"Kline","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.niox.2020.01.004_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pupt.2011.10.005","article-title":"Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism","volume":"25","author":"Watts","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.niox.2020.01.004_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1538-7836.2007.02461.x","article-title":"Platelet activation in acute pulmonary embolism","volume":"5","author":"Chung","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib5","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/jth.12422","article-title":"Mechanisms of hemolysis-associated platelet activation","volume":"11","author":"Helms","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2017.05.009","article-title":"Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism","volume":"155","author":"Rezania","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.niox.2020.01.004_bib7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00726-015-1986-1","article-title":"A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite?","volume":"47","author":"Gambaryan","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.niox.2020.01.004_bib8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.97.15.1481","article-title":"Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo","volume":"97","author":"Gries","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2020.01.004_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0037-1613804","article-title":"Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers","volume":"83","author":"Gries","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/jth.12711","article-title":"Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo","volume":"12","author":"Apostoli","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.18388\/abp.2004_3562","article-title":"Nitric oxide and platelet energy metabolism","volume":"51","author":"Tomasiak","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.niox.2020.01.004_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.niox.2020.01.004_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.niox.2020.01.004_bib14","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2020.01.004_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.10","article-title":"Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"97","author":"Dasgupta","year":"2015","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2020.01.004_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.atherosclerosis.2011.06.042","article-title":"Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free\/oxidised sGC","volume":"218","author":"Ahrens","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.niox.2020.01.004_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047223","article-title":"Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway","volume":"7","author":"Mendes-Silverio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2020.01.004_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13286","article-title":"The sGC stimulator Riociguat inhibits platelet function in washed platelets but not in whole blood","author":"Reiss","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2020.01.004_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vph.2010.09.008","article-title":"Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase","volume":"53","author":"Roger","year":"2010","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.niox.2020.01.004_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704484","article-title":"Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies","volume":"135","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2020.01.004_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.niox.2019.01.006","article-title":"Inhaled nitric oxide to treat intermediate risk pulmonary embolism: a multicenter randomized controlled trial","volume":"84","author":"Kline","year":"2019","journal-title":"Nitric Oxide: Biol. Chem."},{"key":"10.1016\/j.niox.2020.01.004_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ahj.2017.01.011","article-title":"Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: the iNOPE trial","volume":"186","author":"Kline","year":"2017","journal-title":"Am. Heart J."},{"key":"10.1016\/j.niox.2020.01.004_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/emermed-2013-202426","article-title":"Pilot study of a protocol to administer Inhaled nitric oxide to treat severe acute submassive pulmonary embolism","volume":"31","author":"Kline","year":"2014","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.niox.2020.01.004_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchromb.2006.07.018","article-title":"Analysis of nitrite and nitrate in biological samples using high-performance liquid chromatography","volume":"851","author":"Jobgen","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.niox.2020.01.004_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.niox.2020.01.004_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2009-01-198309","article-title":"Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging","volume":"114","author":"Nielsen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.niox.2020.01.004_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10557-008-6098-7","article-title":"Platelet hyperaggregability: impaired responsiveness to nitric oxide (\u201cplatelet NO resistance\u201d) as a therapeutic target","volume":"22","author":"Rajendran","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.niox.2020.01.004_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","article-title":"Novel roles of cAMP\/cGMP-dependent signaling in platelets","volume":"10","author":"Smolenski","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.117.109918","article-title":"Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat","volume":"93","author":"Kollau","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.niox.2020.01.004_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/ars.2016.6693","article-title":"Structure and activation of soluble guanylyl cyclase, the nitric oxide sensor","volume":"26","author":"Montfort","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2020.01.004_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2015.6591","article-title":"Thiol-based redox modulation of soluble guanylyl cyclase, the nitric oxide receptor","volume":"26","author":"Beuve","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2020.01.004_bib32","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1053\/euhj.2002.3296","article-title":"Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide","volume":"23","author":"Willoughby","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2020.01.004_bib33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1538-7836.2009.03535.x","article-title":"Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation","volume":"7","author":"Kline","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.thromres.2015.08.017","article-title":"Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism","volume":"136","author":"Kline","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.niox.2020.01.004_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1538-7836.2009.03704.x","article-title":"Rapid clearance of circulating haptoglobin from plasma during acute pulmonary embolism in rats results in HMOX1 up-regulation in peripheral blood leukocytes","volume":"8","author":"Zagorski","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.niox.2020.01.004_bib36","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/s41467-018-06638-8","article-title":"A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis","volume":"9","author":"Wen","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860319302496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860319302496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:04:46Z","timestamp":1761069886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860319302496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"alternative-id":["S1089860319302496"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2020.01.004","relation":{},"ISSN":["1089-8603"],"issn-type":[{"type":"print","value":"1089-8603"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled nitric oxide to control platelet hyper-reactivity in patients with acute submassive pulmonary embolism","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2020.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}